URG101
URG101 is a combination of lidocaine and heparin instilled directly into the bladder via catheter.
Developing and Commercializing Innovative Products for Urological Indications
Urigen Pharmaceuticals develops and commercializes innovative products for urological indications, including treatments related to IC/BPS.
Products in DevelopmentURG501
URG501 is a follow-on product for the treatment of IC/BPS.
Learn About IC/BPS
Educational content about interstitial cystitis / bladder pain syndrome.
News
- Urigen Pharmaceuticals Initiates Multicenter Phase II Trial: “Evaluation of the Safety and Effectiveness of URG101 in Subjects with Interstitial Cystitis/Bladder Pain Syndrome”